Project description
Innovative platform for bio-based amino acid production
Serine (Ser) and cysteine are two commercially crucial amino acids (AAs) used in a range of applications. However, their production and market potential are limited due to their environmental impact. The EU-funded BioBAA project has advanced a bio-based platform for AA production, the AA platform, which has outstanding environmental and economic performance. The platform was developed by Cysbio, with the use of advanced patented metabolic engineering and synthetic biology methods to combine, balance and tune the different metabolic pathways involved in Ser production. This innovative platform offers the cheapest and most environmentally friendly AAs, allowing companies to replace fossil-based, energy-consuming and polluting processes with bio-based alternatives.
Objective
Serine and Cysteine are two commercially important AAs. However, both present severe limitations regarding their production’s environmental and economic sustainability, which limits their market potential and causing a large negative environmental impact.
Supported by advanced patented-metabolic engineering and synthetic biology approaches Cysbio developed a bio-based platform for AA production - AA-Platform - with an unprecedented environmental and economic performance. Through the design of proprietary cell factories (Escherichia coli), Cysbio was able to combine, balance and tune the different metabolic pathways involved in Ser production.
The accomplishment of the AA-platform performance is also due to: i) the sustainable and cost-efficient bioconversion of Ser into Cys; ii) efficient and multi-sourced (i.e. can use sources of glucose, maltose or glycerol with limited impact on process’s efficiency); and iii) sustainable upstream and downstream processes. Building from these strong value propositions, this innovative platform yields a significant advantage against competitors’ products and will radically change the market, by creating the cheapest AAs (Ser<2.1 €/Kg and Cys<2.5€/Kg and longer term the target is >1 €/Kg and >2 €/Kg respectively) and in an environmentally sustainable manner. This will allow companies and society at large to replace fossil-based, energy consuming and polluting processes and products with sustainable, bio-based alternatives.
Cysbio is currently a small and agile company, whose business strategy is to move quickly into the market by taking a large share of the existing Ser and Cys market segments and by creating a new one, replacing part of Met added in the chicken feed (with a market size of 5.4€Bn) with our sustainable and inexpensive Cys. The BioBAA project is at the core of this strategy and is what drives the company´s mission and future activities for a successful development.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciencesbiological sciencessynthetic biology
- natural sciencesbiological sciencesbiochemistrybiomoleculeslipids
- natural scienceschemical sciencesorganic chemistryamines
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Call for proposal
(opens in new window) H2020-EIC-SMEInst-2018-2020
See other projects for this callSub call
H2020-EIC-SMEInst-2018-2020-4
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
2970 Horsholm
Denmark
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.